CORNERSTONE THERAPEUTICS INC Royalty Expense
CORNERSTONE THERAPEUTICS INC reported Royalty Expense of $2.40 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2013-11-07
- CORNERSTONE THERAPEUTICS INC royalty expense for the quarter ending 2013-09-30 was $2.40M, a 250.88% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC royalty expense for the quarter ending 2013-06-30 was $1.30M, a 8.33% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC royalty expense for the quarter ending 2013-03-31 was $1.20M, a 25.00% decline year-over-year.
- CORNERSTONE THERAPEUTICS INC royalty expense for the quarter ending 2012-12-31 was $1.90M, a 58.33% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC royalty expense for fiscal 2012 was $5.40M, a 28.00% decline from fiscal 2011.
- CORNERSTONE THERAPEUTICS INC royalty expense for fiscal 2011 was $7.50M, a 40.94% decline from fiscal 2010.
- CORNERSTONE THERAPEUTICS INC royalty expense for fiscal 2010 was $12.70M.
| Period end | Royalty Expense 3 month | Royalty Expense 3 month as first filed | Royalty Expense 6 month | Royalty Expense 6 month as first filed | Royalty Expense 9 month | Royalty Expense 9 month as first filed | Royalty Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2013-09-30 | $2.40M 10-Q · filed 2013-11-07 | $3.70M derived: sum of 2 quarters · filed 2013-11-07 | $4.90M 10-Q · filed 2013-11-07 | $6.80M derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2013-06-30 | $1.30M 10-Q · filed 2013-08-06 | $2.50M 10-Q · filed 2013-08-06 | $4.40M derived: sum of 3 quarters · filed 2013-08-06 | $5.08M derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2013-03-31 | $1.20M 10-Q · filed 2013-05-09 | $3.10M derived: sum of 2 quarters · filed 2013-05-09 | $3.78M derived: sum of 3 quarters · filed 2013-11-07 | $4.98M derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2012-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $2.58M derived: sum of 2 quarters · filed 2013-11-07 | $3.78M derived: sum of 3 quarters · filed 2013-11-07 | $5.40M 10-K · filed 2013-03-14 | |||
| 2012-09-30 | $684.00K 10-Q · filed 2012-11-08 | $1.88M derived: sum of 2 quarters · filed 2013-11-07 | $3.50M 10-Q · filed 2013-11-07 | $4.68M derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2012-06-30 | $1.20M 10-Q · filed 2013-08-06 | $2.80M 10-Q · filed 2013-08-06 | $4.00M derived: sum of 3 quarters · filed 2013-08-06 | $5.60M derived: sum of 4 quarters · filed 2013-08-06 | |||
| 2012-03-31 | $1.60M 10-Q · filed 2013-05-09 | $2.80M derived: sum of 2 quarters · filed 2013-05-09 | $4.40M derived: sum of 3 quarters · filed 2013-05-09 | $6.50M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $2.80M derived: sum of 2 quarters · filed 2013-03-14 | $4.90M derived: sum of 3 quarters · filed 2013-03-14 | $7.50M 10-K · filed 2013-03-14 | |||
| 2011-09-30 | $1.60M 10-Q · filed 2012-11-08 | $1.60M 10-Q · filed 2011-11-03 | $3.70M derived: sum of 2 quarters · filed 2012-11-08 | $6.30M 10-Q · filed 2012-11-08 | $6.25M 10-Q · filed 2011-11-03 | ||
| 2011-06-30 | $2.10M 10-Q · filed 2012-08-09 | $2.15M 10-Q · filed 2011-08-04 | $4.60M 10-Q · filed 2012-08-09 | $4.64M 10-Q · filed 2011-08-04 | |||
| 2010-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $5.45M derived: sum of 2 quarters · filed 2013-03-14 | $8.10M derived: sum of 3 quarters · filed 2013-03-14 | $12.70M 10-K · filed 2013-03-14 | |||
| 2010-09-30 | $2.60M 10-Q · filed 2011-11-03 | $5.25M derived: sum of 2 quarters · filed 2011-11-03 | $9.85M 10-Q · filed 2011-11-03 | ||||
| 2010-06-30 | $2.65M 10-Q · filed 2011-08-04 | $7.25M 10-Q · filed 2011-08-04 |